Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 3/20 | 0.48 |
| ▸ | NOS2 | P35228 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.46 |
| ▸ | MMP2 | P08253 | 4/20 | 0.44 |
| ▸ | MMP9 | P14780 | 3/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25387266 | 1.00 | MME (0.48) | MMENOS2NPSR1NAALAD2MMP2 | |
| SCHEMBL29214532 | 0.84 | MME (0.58) | MMENOS2NPSR1NAALAD2L3MBTL1 | |
| SCHEMBL1135185 | 0.84 | MME (0.58) | MMENOS2NPSR1NAALAD2L3MBTL1 | |
| SCHEMBL1135183 | 0.84 | MME (0.58) | MMENOS2NPSR1NAALAD2L3MBTL1 | |
| SCHEMBL4432859 | 0.83 | MMP8 (0.49) | L3MBTL1ALDH1A1 | |
| SCHEMBL157547 | 0.81 | MME (0.61) | MMENPSR1NAALAD2MMP2MMP9 | |
| SCHEMBL29064035 | 0.79 | MME (0.51) | MMENPSR1NAALAD2L3MBTL1CYP1A2 | |
| SCHEMBL11262817 | 0.79 | MME (0.51) | MMENPSR1NAALAD2L3MBTL1CYP1A2 | |
| SCHEMBL27850341 | 0.79 | MME (0.51) | MMENPSR1NAALAD2L3MBTL1CYP1A2 | |
| SCHEMBL5389540 | 0.78 | MME (0.57) | MMENPSR1NAALAD2MMP2MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4490202-A1 | CYCLOPEPTIBODIES AND USES THEREOF | University of Rochester (US) | 2025-01-15 | — | — | EP | claimed |
| CN-118892583-A | High-wet tissue adhesion anti-swelling conductive hydrogel and preparation method thereof | 西安交通大学 | 2024-11-05 | — | — | CN | claimed |
| WO-2023173084-A9 | CYCLOPEPTIBODIES AND USES THEREOF | UNIVERSITY OF ROCHESTER (US) | 2023-12-14 | — | — | WO | claimed |
| WO-2023173084-A1 | CYCLOPEPTIBODIES AND USES THEREOF | UNIVERSITY OF ROCHESTER (US) | 2023-09-14 | — | — | WO | claimed |
| CN-109206617-B | Method for resolving racemic compound by fractional crystallization | 北京大学 | 2020-04-24 | — | — | CN | claimed |
| CN-118892583-B | High-wet tissue adhesion anti-swelling conductive hydrogel and preparation method thereof | 西安交通大学 | 2026-05-12 | — | — | CN | disclosed |
| CN-118892583-A | High-wet tissue adhesion anti-swelling conductive hydrogel and preparation method thereof | 西安交通大学 | 2024-11-05 | — | — | CN | disclosed |
| WO-2023173084-A9 | CYCLOPEPTIBODIES AND USES THEREOF | UNIVERSITY OF ROCHESTER (US) | 2023-12-14 | — | — | WO | disclosed |
| WO-2023173084-A1 | CYCLOPEPTIBODIES AND USES THEREOF | UNIVERSITY OF ROCHESTER (US) | 2023-09-14 | — | — | WO | disclosed |
| CN-109206617-B | Method for resolving racemic compound by fractional crystallization | 北京大学 | 2020-04-24 | — | — | CN | disclosed |